$MGX Balance Sheet | Understand Stock

$MGX

$0.82 +$0.02 (2.71%) Close

$MGX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024
Assets
Current assets:
Cash and cash equivalents
Available-for-sale marketable securities
Accounts receivable
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Long-term investments
Operating lease right-of-use assets
Other assets
Restricted cash
Total assets
Liabilities, Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit)
Current liabilities:
Accounts payable
Income tax payable
Accrued expenses and other current liabilities
Current portion of operating lease liabilities
Collaboration advance
Deferred revenue
Total current liabilities
Non-current portion of operating lease liabilities
Deferred revenue, non-current
Other non-current liabilities
Total liabilities
Commitments and contingencies (Note 8)
Redeemable convertible preferred stock: zero shares authorized, issued and outstanding as of September 30, 2024; 41,813,375 shares authorized, issued and outstanding as of December 31, 2023; liquidation preference of $352,044 as of December 31, 2023
Stockholders' equity (deficit):
Preferred stock: $0.0001 par value; 10,000,000 shares authorized and zero shares issued and outstanding
Common stock: $0.0001 par value; 500,000,000 shares authorized; 37,777,105 and 37,620,668 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in-capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Total stockholders' equity
Total liabilities and stockholders' equity

Comments